CS-8958, a Prodrug of the Novel Neuraminidase Inhibitor R-125489, Demonstrates a Favorable Long-Retention Profile in the Mouse Respiratory Tract

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00731-09
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Laninamivir Prodrug CS-8958, a Long-Acting Neuraminidase Inhibitor, Shows Superior Anti-Influenza Virus Activity After a Single Administration

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2010English

Estimation of the Retention of Menthol in the Respiratory Tract of Menthol Cigarette Smokers: A Pilot Study

Contributions to Tobacco Research
2014English

Neuraminidase Inhibitor Therapy in a Military Population

Journal of Clinical Virology
VirologyInfectious Diseases
2015English

Pharmacological Profiles of CS-622, a Novel Angiotensin Converting Enzyme Inhibitor.

The Japanese Journal of Pharmacology
1988English

Synthesis and Characterization of a Novel Prostate Cancer-Targeted Phosphatidylinositol-3-Kinase Inhibitor Prodrug

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2012English

Fitness of Neuraminidase Inhibitor-Resistant Influenza a Viruses

Current Opinion in Virology
Virology
2011English

Response to Comment on "A Novel Pathway That Regulates Inflammatory Disease in the Respiratory Tract"

Journal of Immunology
AllergyImmunology
2007English

Adaptation of an ICAM-1-Tropic Enterovirus to the Mouse Respiratory Tract

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2011English

The PTTG1 Is a Novel Inhibitor of Osteogenic Differentiation of Mouse Mesenchymal Stem Cells

The Animal Biology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy